Sangbeom Lee, PhD
Sangbeom Lee received her PhD in Life Sciences & Biotechnology at Korea University in South Korea. After graduation, He joined Dr. Yian Wang’s lab as a postdoctoral research fellow in 2014. He joined Dr. Ming You’s lab as research associate in 2021. He works in the field of chemoprevention and immunoprevention of triple negative breast cancer on mouse model.
Qian Li, PhD
Qian Li is a biomedical engineering major by training and received her PhD in Sichuan University in 2025. After graduation, she joined Dr. Ming You’s lab as a postdoctoral research fellow in 2025. Her current research interest is focused on the synthesis of novel mitochondria-targeting drug and therapeutic applications thereof.
Yian Wang, PhD
Yian Wang received her BS/MD in Beijing University School of Medicine and PhD in University of Toledo School of Medicine. She interested in cancer biology, focused on cancer chemoprevention and immunoprevention. She joined the YOU team in May 2021 at the Houston Methodist Research Institute, working on the immunoprevention of breast cancer and lung cancer.
Jing Pan, PhD
Jing Pan received her PhD in Cell Biology from Lanzhou University in China. Dr. Pan joined Dr. Ming You’s lab as a postdoc research fellow at the Washington University in St. Louis in 2009; was promoted to Research Associate Professor at Medical College of Wisconsin in 2020; and was recruited as Associate Research Professor at the Houston Methodist Research Institute in 2021. Dr. Pan’s research primarily focuses on identifying potent chemopreventive agents for lung cancer, development of vaccines to prevent cancers, and defining the mechanisms by which preventive agents or vaccines regulate anti-cancer responses.
Qi Zhang, PhD
Qi Zhang received his PhD at Lanzhou University in China. In 2008, he joined Dr. Ming You’s lab as a postdoctoral research fellow at Washington University in St. Louis. In 2020, he was promoted as Research Associate Professor at Medical College of Wisconsin. In 2021, he was recruited as Associate Research Professor at The Houston Methodist Research Institute. His research includes 1) aerosolized treatment in lung cancer; 2) the discovery of Mitochondria-targeted agents.